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Histocompatibility loci have been classified as major histocompatibility complex 
(MHC) or minor histocompatibility complex (non-MHC) based on the time-course of 
in vivo graft rejection, the relative ease with which alloantiserum may be produced, 
and the characteristics of the in vitro mixed-leukocyte culture (MLC)  (1).  Attempts 
to sensitize cytotoxic lymphocytes (To) against  minor histocompatibility antigens in 
vitro have failed (2-5). This does not seem to reflect the absence ofnon-MHC-antigen- 
recognizing Tc precursor cells;  in  vivo or in  vitro primed lymphocytes, secondarily 
challenged in vitro, give rise to strong cytotoxic responses (6-8). Because the immu- 
nological  outcome of antigenic  challenge  most  probably depends  upon  a  balance 
between  positive  and  negative  influences  on  certain  fundamental  pathways,  we 
theorized that the failure to induce primary Tc in MHC-identical, non-MHC-dispar- 
ate strain  combinations  might  be a  result  of either a  suppressive mechanism  that 
impedes T¢ development, or the absence of appropriate amplification  mechanisms. 
We sought evidence for this hypothesis by testing cytotoxic responses of anti-la serum 
plus complement-treated lymphocytes cultured  in  vitro with  MHC-identical,  non- 
MHC-disparate stimulating cells. We selected this approach on the basis of evidence 
for differential expression of I-region  determinants  on  regulatory T  cells  in  other 
systems (9), and the strong reactivity of the antiserum used herein with T lymphocytes 
(10).  Our  results  demonstrate  that  the  responding cells  that  remain  can  mount  a 
highly significant primary, in vitro T¢ response to non-MHC antigens in several strain 
combinations. 
Materials and Methods 
Animals.  B 10.BR, B 10.D2, and B 10.S mice were bred in our colony (University of Wisconsin, 
Madison,  Wis.).  C3H/HeJ,  AKR/J,  BALB/c,  and  CBA/J  mice  were  purchased  from  The 
Jackson Laboratory, Bar Harbor, Maine. Male and female animals 6-12 wk of age were used. 
Guinea pigs were obtained from Mogul Ed., Oshkosh, Wis. 
Media.  All  media  and  supplements  were  purchased  from Grand  Island  Biological  Co., 
Grand Island, N. Y. Hanks' balanced salt solution without bicarbonate was supplemented with 
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0.05 M Hepes buffer (HBSS). Mishell-Dutton medium (11), freshly prepared and supplemented 
with 5  ×  10  -5 M  2-mercaptoethanol and  2%  heat-inactivated fetal calf serum  (FCS)  (Flow 
Laboratories, Inc., Rockville, Md.), was used throughout. Cytotoxicity assays were performed 
in cell culture medium fortified with 5% FCS. 
Antisera.  (A.TH ×  B10.HTT)F1 anti-A.TL serum, hereafter termed anti-Ia, was prepared 
by concanavalin A  (Con A) thymocyte blast immunization as described by Hayes and Bach 
(12). The method of Reif and Allen (13) was used to prepare anti-Thy-1.2 serum. Antisera were 
tested by a  two-stage, dye-exclusion microcytotoxicity test (12).  Anti-Ia serum lysed >50% of 
A.TL lymph node cells, with half-maximal lysis at a  1:1,280 dilution. Anti-Thy-1.2 lysed >95% 
of C3H/HeJ thymocytes, with half-maximal lysis at a  1:640 dilution. Fresh guinea pig serum, 
obtained bimonthly by heart puncture, served as complement (C). For anti-Ia serum lysis of 
splenocytes, cells were suspended in HBSS-diluted antiserum (1.0 ml of 1:20/5 ×  107 cells) and 
incubated on ice for 15 min. 10 vol of cold HBSS were added, the cells pelleted (1,000  rpm, 10 
min), and resuspended in HBSS-diluted C  (1.0 ml of 1:25/5 ×  10 7 cells). After 30 min at 37°C, 
the  cells  were  washed  twice  with  HBSS  and  resuspended  in  culture  medium.  Cultured 
lymphocytes were lysed with anti-Thy-l.2 serum plus C according to the same protocol, except 
that serum was diluted 1:15, C was absorbed with mouse spleen cells (5 ml of 1:5-diluted C;  1 
×  108 cells; 15 min on ice), and the treatment was repeated one additional time. For absorption 
experiments, HBSS-diluted anti-Ia serum (1.0 ml of 1:20) was absorbed twice (15 rain on ice) 
with either B 10.S or B10.BR splenocytes (1 ×  108 cell/absorption). 
Cell Counting.  Cell viability was determined by trypan blue exclusion staining. Cell concen- 
trations are expressed as viable cells per milliliter. 
MLC.  Responding splenocytes, either untreated  or treated with  antiserum  and  C,  were 
suspended in culture medium and aliquoted into microtiter wells (5 ×  105 cell/well) (No.  76- 
002-05, Linbro Chemical Co., Hamden, Conn.). X-irradiated (2,000 R), stimulating splenocytes, 
suspended in culture medium, were aliquoted into wells (5 ×  105 cell/well). Total cell culture 
vol was 0.2 ml. In some experiments, 24-well culture plates (No.  76-033-05,  Linbro Chemical 
Co.)  were used  (5  ×  106  cells of each  type;  2.0  ml).  After 5-6  d  at  37°C  in  a  humidified 
atmosphere of 5% CO2 in air, replicate cultures were resuspended with a Pasteur pipet, pooled, 
washed with HBSS, and resuspended in fresh medium with 5%  FCS  (2.5  ×  106 cell/ml) for 
cytotoxicity assay. 
Cell-mediated  Lympholysis Assay.  Blast cell targets were prepared 48 h beforehand by adding 
Con A  (2.5/Lg/ml; Pharmacia Fine Chemicals, Inc., Uppsala, Sweden) to replicate cultures of 
splenocytes in medium with 5% FCS (15 ×  106 cell/3 ml; 35 ×  10-mm tissue culture dishes; No. 
3001, Falcon Labware, Div. of Becton, Dickinson & Co., Oxnard, Calif.). To an aliquot of Con 
A-stimulated blast cells (5 ×  106 cells in 0.3 ml HBSS with 5% FCS) was added Na2 ~1CrO4 (50 
/~1 of 5 mCi/ml; New England Nuclear, Boston, Mass.), and the mixture was incubated at 37°C 
for 1 h, resuspending the cells at  15-min intervals. 5XCr-labeled cells, washed three times with 
HBSS, were resuspended in medium with 5% FCS at 5 ×  104 cell/ml. 
5XCr-release assays were performed  in  microtiter plates  (No.  76-011-05,  Linbro Chemical 
Co.). Appropriately diluted effector cell suspensions (0.1 ml)  followed by ~]Cr-labeled target 
cells (0.1 ml) were dispensed into each of four replicate wells. Six replicate wells of medium and 
target cells served as background controls; six wells of detergent (0.5% Nonidet P40, Shell Oil 
Co., Houston, Tex.) and target cells gave maximal 51Cr-release  values. Plates were centrifuged 
(250 g, 5 min) then incubated for 8 h at 37°C in a humidified atmosphere of CO2 in air. A  100- 
/xl sample was removed from each well and counted in a Packard 5320 auto gamma scintillation 
spectrometer (Packard Instrument Co., Inc., Downers Grove, Ill.). 
Data  Calculation,  Presentation,  and  Statistical  Evaluation.  Percent  specific  51Cr release  was 
calculated for each replicate sample according to the formula: 
I  experimental release (counts per minute)  1 
-  background release (counts per minute) 
Percent specific ~lCr release =  100  maximal release (counts per minute) 
-  background release (counts per minute) 
The mean value of replicate samples _  SD is presented. HAYES,  MACPHAIL,  AND  BACH 
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FIG.  1.  (Left)  Primary cytotoxic  responses are developed  in vitro by anti-Ia serum plus C-treated 
lymphocytes  against H-2-identical,  non-MHC-disparate  stimulating cells.  Untreated  B10.BR cells 
cultured alone (A), NMS +  C-treated B 10.BR  cells cultured with X-irradiated CBA cells  (O), and 
anfi-Ia +  C-treated B10.BR cells cultured with X-irradiated CBA cells (O) were assayed on day 6 
for cytotoxic activity on 5aCr-labeled CBA target cells. 
Flo.  2.  (Right) Primary cytotoxic responses are developed in vitro by anti-Ia serum plus C-treated 
lymphocytes  against  a  variety  of H-2-identical,  non-MHC-disparate  stimulating  (Stim.)  strains. 
Responding  (Resp.)  cells are either  untreated  ([--1), NMS  +  C  treated  (M), or anti-Ia serum  +  C 
treated  ~).  a, effector:target  ratio 50:1.  b, phytohemagglutinin  blast, 4-h assay. 
Results 
Primary cytotoxic responses are developed in vitro by anti-Ia serum- and C-treated 
B10.BR  (H-2 k)  lymphocytes against H-2-identical,  non-MHC-disparate  CBA/J  (H- 
2 k) stimulating cells (Fig.  1). B 10.BR cells, untreated and cultured alone, or pretreated 
with  normal  mouse  serum  (NMS)  and  C  and  cultured  with  X-irradiated  CBA/J 
stimulating cells, do not show significant cytotoxicity against ~lCr-labeled CBA blas.ts 
after 6 d in culture. No autokilling of B10.BR targets was observed. 
The ability to generate cytotoxicity to non-MHC antigens in a  primary  MLC,  if 
the responding cells are first  treated with anti-Ia serum and C, can be demonstrated 
in several different  strain combinations  (Fig.  2). In each experiment, cytotoxicity on 
the relevant  target cell  is compared  for untreated., unstimulated cells;  NMS  and C- 
treated  cells  stimulated  with  X-irradiated,  non-MHC-disparate  cells;  and  anti-Ia 
serum  and  C-treated  cells  stimulated  with  X-irradiated  non-MHC-disparate  cells. 
Three  combinations  are shown  that  represent  two different  responding strains  and 
two  different  sensitizing  strains.  In  each  case,  significant  cell-mediated  iysis  was 
observed only in the anti-Ia serum plus C-treated group. Lysis appeared to be antigen 
specific  in that target cells of other strains were  not lysed  (C3H  primed  with CBA. 
did not lyse B10.D2  or AKR  targets;  B10.BR  primed  with AKR  did not lyse CBA 
targets;  B10.BR  primed  with CBA  did  not lyse AKR  targets  [data not shown]). In 
some instances, cross-reactivity was observed. For example, CBA-primed B 10.BR cells 
lysed CBA (40.1 ±  11.1%) and to a lesser extent BALB/c targets (13.0 +  9.6%)  in one 
experiment,  and  CBA  (67.0  +__ 9.6%)  and  C3H  targets  (48.6  _  5.2%)  in  a  second 
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The  cytotoxic cells  that  develop  upon  culture  of anti-Ia  serum  plus  C-treated 
B 10.BR responding lymphocytes with (2BA stimulating cells bear the Thy-1.2 antigen. 
In vitro primed cytotoxic effector cells, derived from cultures of anti-Ia serum and (2- 
treated responding cells, were tested for their susceptibility to anti-Thy-1.2 serum and 
(2 lysis immediately before the cell-mediated lympholysis assay:  untreated cytotoxic 
cells lysed (2BA targets (22.6 -  4.9%)  as did NMS and C-treated cells (20.5 _  4.9%). 
Two-cycle anti-Thy-l.2  plus  (2  treatment  virtually  eliminated  cytotoxicity (3.4  _ 
3.1%). Thus, the cytotoxic effector cells appear to be T  cells. 
The anti-Ia serum  used  in  these experiments has  been extensively characterized 
with regard to its haplotype specificity (10). Absorption results confirmed this speci- 
ficity: B10.BR  cells  that  remained  after treatment  with  unabsorbed  anti-Ia serum 
and (2 lysed (2BA targets  (29.0 _  8.7%)  after being cultured 6 d  in vitro with (2BA 
stimulating cells. When anti-Ia serum was first absorbed with B 10.BR or (23H spleen 
cells, Tc did not develop (-8.7 __. 7.3%). On the other hand, anti-Ia serum retained its 
reactivity after absorption with B10.S spleen cells (28.0 +_  11.1%). 
Discussion 
The results presented in this paper demonstrate that responding cells that remain 
after anti-Ia serum and (2 treatment generate a  highly significant cytotoxic response 
against non-MH(2 antigens:  NMS and (2-treated control cells do not. The cytotoxic 
response appears to be antigen specific in that  target cells of strains other than the 
sensitizing strain  are  not  lysed, or lysed to a  lesser extent.  The cytotoxic cells  are 
susceptible to anti-Thy-l.2 and (2 lysis. Thus, they appear to be To. 
The  anti-Ia  serum  employed in  these  studies  has  been  well  characterized  with 
respect  to  its  specificity (10).  It  contains  antibody  to  both  I-A  k-  and  I-jk-encoded 
antigens;  I-B  k,  Qa,  and  Tla  activity  were  not  observed  (10).  Experiments  are  in 
progress to determine which  antiserum  component(s)  are necessary to bring about 
non-MH(2-Tc induction. 
Since the advent of transplantation, immunogeneticists have questioned the basis 
of phenomenological distinctions between major and minor transplantation antigens. 
One  hypothesis  to  explain  some  characteristic  immunological  differences between 
these antigens suggests that Tc development is subject to suppressive and enhancing 
regulatory influences; strong and  weak antigens  might  then differ primarily in  the 
overall balance between such regulatory mechanisms that they elicit and, therefore, 
in their ability to induce To. The results presented here can be interpreted in view of 
this  hypothesis  by  suggesting  that  anti-Ia  serum  plus  (2  might  remove  from  the 
responding cell population a  cellular component of a  non-MH(2-antigen-activated 
suppressive mechanism, permitting unimpeded non-MH(2-T~ generation in antigen- 
stimulated cultures (S.  M.  Macphail and F.  H. Bach. (2ytotoxicity and suppression 
induced by in vitro responses to non-H-2 histocompatibility antigens. Manuscript in 
preparation.). This interpretation is strengthened by two lines of experimental evi- 
dence. First, I-J-antigen-bearing suppressor T cells have been demonstrated in several 
systems  (14,  15).  Second, lymphocytes from non-MH(2-antigen-primed donors pro- 
duce an ML(2 proliferation-suppressing factor (16)  and block the differentiation of 
MH(2-specific memory T~ when these are restimulated with antigen in vitro (17).  If 
this interpretation is correct, and we regard it as a  likely mechanism, this would be 
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(To)  to non-MHC-antigens,  and  the existance of Ia-antigen-bearing, unprimed  sup- 
pressor cells in vitro. 
Other  mechanisms  by which  anti-Ia serum  and  C  may function  cannot  be ruled 
out.  For instance, anti-Ia antibody may activate a  dormant  helper cell, or deliver a 
second requisite signal to a  non-MHC-specific Tc precursor. Further experimentation 
should permit us to distinguish which of these possibilities is correct. 
Summary 
The results presented in this paper demonstrate that responding cells that remain 
after anti-Ia serum  plus complement  (C)  treatment  generate a  highly significant in 
vitro  cytotoxic  response  against  minor  histocompatibility  complex  antigens.  The 
cytotoxic response appears to be antigen specific in that  target cells of strains other 
than the sensitizing strain are not lysed, or lysed to a  lesser extent. The cytotoxic cells 
are susceptible to anti-Thy-1  plus C  lysis. Anti-Ia serum  may function by removing 
an unprimed suppressor cell, although other mechanisms cannot  be ruled out. 
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